Pressure Ulcers Market to Reach $5.6 Billion by 2031, Growing at 4.2% CAGR – Allied Market Research

Pressure Ulcers Market to Reach $5.6 Billion by 2031, Growing at 4.2% CAGR – Allied Market Research

PR Newswire

Rising Geriatric Population, Surge in Hospital-Acquired Pressure Injuries, and Advanced Wound Care Innovations Drive Global Pressure Ulcers Treatment Market Growth

PORTLAND, Ore., April 15, 2026 /PRNewswire/ — According to a recent report published by Allied Market Research, titled ‘Pressure Ulcers Market,’ the global pressure ulcers market was valued at $3.7 billion in 2021 and is estimated to reach $5.6 billion by 2031, growing at a CAGR of 4.2% from 2022 to 2031. The market is primarily driven by the rising incidence of pressure ulcers also known as bedsores, pressure sores, or decubitus ulcers in aging and immobile patient populations, increasing demand for advanced wound care dressings and devices, and a growing focus on preventive wound management protocols across hospitals and homecare settings worldwide.

Request Sample of the Report on
Pressure Ulcers Market
Forecast 2031 –
https://www.alliedmarketresearch.com/request-sample/A11263

Market Size & Growth

Key growth drivers include the global surge in the elderly population a demographic highly susceptible to pressure injuries increasing prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions, growing awareness of advanced wound care options among healthcare providers, and rising investments in wound care research and development. According to Wound Management and Prevention, approximately 71% of pressure ulcers develop in patients older than 70 years, placing enormous strain on healthcare systems and driving demand for both preventive and therapeutic wound care solutions.

According to data from the U.S. Department of Health and Human Services, approximately 2.5 million people in the United States develop pressure ulcers annually, with annual treatment costs estimated at $9.1-$11.6 billion. These figures highlight the immense economic burden of pressure ulcer management and the critical need for cost-effective, evidence-based treatment options a need that continues to catalyze innovation and market growth.

Key Market Insights

The pressure ulcers market is shaped by several critical trends and factors that stakeholders must monitor closely:

  • Rising prevalence of hospital-acquired pressure injuries (HAPIs): The prevalence of hospital-acquired pressure injuries is estimated at 8.5% in adult patients, according to available research, increasing pressure on healthcare facilities to adopt advanced prevention and treatment protocols.
  • Technological innovation in wound care: The market is witnessing growing adoption of smart mattresses, dynamic air therapy support surfaces, microclimate management systems, and AI-driven wound imaging analytics that enable real-time wound monitoring and improved clinical outcomes.
  • Shift toward preventive wound care: Since treating pressure ulcers is significantly more expensive than preventing them, the industry is actively pivoting toward preventive care, with advanced movement monitoring systems and pressure-redistributing support surfaces gaining mainstream adoption in hospitals and long-term care facilities.
  • Impact of COVID-19 on pressure ulcer incidence: The pandemic created a notable secondary effect on the market patients with acute respiratory distress syndrome (ARDS) requiring prone positioning for 12-16 hours showed elevated risk of pressure injuries, temporarily boosting demand for specialized wound care products and protocols.
  • Homecare segment momentum: The homecare end-user segment is expected to register the fastest CAGR during the forecast period, driven by shifting patient preferences toward home-based treatment, availability of advanced homecare wound care protocols, and an aging population increasingly managing chronic conditions outside hospital settings.
  • Market restraints: High costs associated with advanced wound care biologics, side effects of pharmacological treatments such as nausea and blood pressure fluctuations, and limited access to specialized wound care in low and middle-income countries continue to pose challenges to market growth.

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A11263

Market Segmentation

The global pressure ulcers market is comprehensively segmented by ulcer stage/type, treatment type, and end user.


By Ulcer Stage/Type:

The stage 1 segment held the largest market share in 2021, attributed to the high incidence of stage 1 injuries and corresponding early treatment adoption. Stage 2 ulcers, however, are projected to record the fastest CAGR during the forecast period consistent with data from the American Journal of Critical Care, which indicated a 45% incidence rate for stage 2 pressure ulcers in 2020. Stage 4 ulcers, which carry the highest treatment cost (approximately $16,618 per episode according to NICE), represent a significant revenue contributor, underscoring the economic weight of late-stage pressure injuries.


By Treatment Type:

The wound care dressings segment dominated the market in 2021, a position it is expected to retain through the forecast period, owing to their primary role in wound healing acceleration and widespread clinical adoption. The wound care devices segment is anticipated to grow at the fastest CAGR of 5.6% during the forecast period, propelled by technological advancements in Negative Pressure Wound Therapy (NPWT) systems, smart monitoring platforms, and dynamic support surfaces. Active wound care therapies including bioelectric bandages, collagen-based dressings with epidermal growth factors, and extracellular matrix products represent a rapidly emerging sub-segment driven by clinical efficacy and product innovation.


By End User:

Hospitals dominated the end-user segment in 2021 and are expected to maintain leadership throughout the forecast period. This is primarily due to the high adoption of advanced wound care products in hospital settings, growing institutional investments in patient safety infrastructure, and favorable reimbursement policies. The homecare segment is the fastest-growing end-user category, reflecting a broader shift in patient management from acute care facilities to home settings especially among the elderly population managing long-term wound care needs.

Regional Insights

The pressure ulcers market is geographically segmented into North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa).

  • North America dominated the global market in 2021 and is expected to maintain its leadership position through 2031, growing at a CAGR of 3.4%. The region benefits from advanced healthcare infrastructure, a high density of skilled wound care professionals, robust R&D investment in wound care innovation, and a strong presence of global market leaders. The U.S. alone accounts for approximately 2.5 million pressure ulcer cases annually, representing a major and consistent demand driver for both treatment and prevention solutions.
  • Europe represents the second-largest regional market, supported by an aging population, strong public healthcare systems, and increasing government mandates to reduce hospital-acquired pressure injuries. Collaborative research initiatives such as guidelines issued jointly by Örebro University, Örebro University Hospital, and Ghent University for preventing pressure ulcers in respiratory support patients are contributing to clinical standardization and improved outcomes.
  • Asia-Pacific is projected to register the fastest regional CAGR of 5.3% from 2022 to 2031. Rapid growth is driven by rising incidence of pressure ulcers, a large and growing geriatric population (especially in China, India, and Japan), increasing healthcare expenditure, expanding access to advanced wound care products, and heightened patient awareness. The region also offers significant market opportunity due to improving healthcare infrastructure and increasing penetration of international wound care brands.
  • LAMEA is an emerging market with growing potential, driven by increasing healthcare investments, improving wound care awareness campaigns, and a rising burden of non-communicable diseases that predispose patients to pressure injuries. Challenges related to healthcare access and cost-effective product availability remain key restraints in this region.

For Purchase Related Queries/Inquiry –

https://www.alliedmarketresearch.com/purchase-enquiry/A11263

Key Players in the Pressure Ulcers Market

The competitive landscape of the global pressure ulcers market is moderately fragmented, with a mix of multinational corporations and regional specialty players actively competing through product innovation, strategic collaborations, mergers and acquisitions, and geographic expansion. The key players profiled in the Allied Market Research report include:

  • Smith & Nephew plc (UK) – Market leader with ALLEVYN foam dressings, PICO NPWT systems, and the LEAF Patient Monitoring System for pressure injury prevention
  • Mölnlycke Health Care AB (Sweden) – Known for its Mepilex silicone-based dressings; strong focus on clinical efficacy, sustainability, and gentle wound management
  • ConvaTec Group plc (UK) – Offers the AQUACEL Hydrofiber technology line and ConvaMax superabsorber dressings; significant NPWT and skin care portfolio
  • 3M Health Care (US) – Provides a broad range of wound care solutions and dressings deployed across acute and long-term care settings
  • B. Braun Melsungen AG (Germany) – A diversified medical device and wound care solutions provider with strong European market presence
  • Coloplast A/S (Denmark) – Focused on innovative wound care products targeting personalized patient outcomes
  • Hill-Rom Holdings Inc. / Baxter International – Offers Centrella Smart+ bed with integrated microclimate management for pressure injury prevention
  • Stryker Corporation (US) – IsoAir mattress systems and pressure-redistributing support surfaces for acute and long-term care environments
  • Arjo AB (Sweden) – Nimbus dynamic air therapy mattresses and support surfaces for pressure ulcer prevention
  • Cardinal Health, Inc. (US) – Broad distribution and wound care product supply across hospital and homecare channels
  • Integra LifeSciences (US) – Advanced regenerative medicine and wound care solutions
  • Acelity L.P. Inc. (US) – Active in NPWT and advanced wound management technologies

Key Recent Industry Developments

The pressure ulcers market has witnessed a series of strategic product launches, clinical validations, and corporate activities that underscore the market’s dynamic growth momentum:

  • April 2024 – Smith+Nephew launched RENASYS EDGE, a compact and patient-centric Negative Pressure Wound Therapy (NPWT) system in the U.S., designed to address the burden of chronic wounds including pressure ulcers. The system’s lightweight design supports patient mobility and reduces treatment complexity.
  • 2025 – Smith+Nephew published new clinical evidence demonstrating the pressure injury prevention mechanism of action of its ALLEVYN COMPLETE CARE Foam Dressing, further validating evidence-based product differentiation in the competitive wound dressing space.
  • April 2023 – ConvaTec Group PLC completed the acquisition of 30 Technology Limited’s anti-infective nitric oxide technical platform, adding novel antimicrobial wound care capabilities to its product pipeline.
  • August 2023 – Medela launched the Invia Integrated Dressing as part of its expanded Negative Pressure Wound Therapy portfolio, broadening treatment options for chronic wound patients.
  • March 2021 – Smith+Nephew released real-world study data from Spain confirming that a clinical shift to ALLEVYN LIFE Foam Dressings resulted in reduced dressing change frequency, lower weekly dressing costs, and improved patient and clinician satisfaction in community care settings.
  • January 2021 – Smith & Nephew acquired Osiris Therapeutics, a regenerative medicine company specializing in skin and bone substitutes, expanding its footprint in advanced wound biologics.
  • January 2020 – ConvaTec Group PLC introduced ConvaMax, a high-performance superabsorber wound dressing indicated for the management of highly exuding wounds including pressure ulcers, diabetic foot ulcers, and leg ulcers.
  • November 2021 – Sanara MedTech Inc. commercially launched FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, developed in partnership with Cook Biotech Inc., expanding the active wound care portfolio for pressure ulcer management.

Analyst Review & Report Access

The Allied Market Research Pressure Ulcers Market report provides in-depth analysis across all market segments, competitive intelligence, and actionable insights for healthcare manufacturers, device companies, investors, and policymakers. The report’s comprehensive scope spanning historical data, base year analysis, and forecast projections through 2031 enables stakeholders to make informed, data-driven decisions in the evolving wound care landscape.

Trending Reports in Healthcare Industry:

Respiratory Inhaler Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Bone Regeneration Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Medical Device Packaging Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

Hyaluronic Acid Products Market – Global Opportunity Analysis and Industry Forecast, 2024-2035

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of «Market Research Reports» and «Business Intelligence Solutions.» AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa1209 Orange Street,Corporation Trust Center,Wilmington, New Castle,Delaware 19801 USA.

Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: [email protected]

Web: https://www.alliedmarketresearch.com

Logo – https://mma.prnewswire.com/media/636519/5918347/Allied_Market_Research_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/pressure-ulcers-market-to-reach-5-6-billion-by-2031–growing-at-4-2-cagr—allied-market-research-302743478.html

contador

0 responses to “Pressure Ulcers Market to Reach $5.6 Billion by 2031, Growing at 4.2% CAGR – Allied Market Research

  1. Pingback: www.negociame.com
  2. Pingback: www.mirlobolsa.com
  3. Pingback: Depósitos Sobre Ruedas de Banesto
  4. Pingback: sacale el maximo rendimiento a tu nomina: nuevas ofertas
  5. Pingback: Domiciliar la nómina: nuevas ofertas | PRÉSTAMOS, HIPOTECAS Y CRÉDITOS
  6. Tengo varias preguntas sobre esto a ver si me podiais aclarar:
    -¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
    -¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
    -No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
    ¿Hay que mantenerlas 13 meses?
    ¿Puedo cancelar alguna de ellas desde el principio?
    ¿Puedo cancelar alguna de ellas antes de la renovación?
    ¿Hay alguna tarjeta de credito más barata?
    Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
    Muchas gracias a todos por responder

  7. Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.

  8. hola buenas!
    me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
    javi

  9. NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.

  10. Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado

  11. Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.

  12. No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.

  13. Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.

  14. Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.

  15. Pingback: Banesto: 1.000 euros por domiciliar nómina
  16. Pingback: 1000 euros por dominiciliar nómina en Banesto
  17. Pingback: Domiciliar la nómina: nuevas ofertas
  18. Pingback: Banesto: Wii de regalo por domiciliar la nómina y tres recibos
  19. Pingback: Regalos por domiciliar nómina en Banesto
  20. hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .

  21. Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!

  22. CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES

  23. Banesto «premia», menuda falacia…
    No hay ningún banco que premie a nadie.
    BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
    DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.

  24. POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
    ES POR DAR PISTAS…